Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma have?
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma has 3,653 citations in the OpenAlex counts ScholarIQ stores.
When was Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma published?
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma has 2007 year in the ScholarIQ index.
What is the open-access status of Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma?
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma has closed oa status in the ScholarIQ index.
What is the DOI of Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma?
The DOI for Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma is on the source record.
What is the PMID of Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma?
The PMID for Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma is on the source record.
What is the OpenAlex record for Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma?
The OpenAlex for Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma is on the source record.